Ivacaftor

Ivacaftor is the chemical name for the Vertex Pharmaceutics drug sold under the brand name Kalydeco. This drug was approved by the FDA in early 2012 to modify the course of cystic fibrosis in patients carrying the rs75527207 variant best known as G551D.